16
nanotimes
Companies Facts
decrease of 6% compared to $105.3 million for the same period in 2009. Net loss under U.S. GAAP in the first half of 2010 was $(3.9) million or $(0.12) per basic and diluted share, compared to net income of $2.1 million or $0.07 per basic and diluted share in the first half of 2009.
AMRI Chairman, President and CEO Thomas E. D‘Ambra said, “Our second quarter results reflect the continued shift in demand from our customers for services in Asia and Europe, as evidenced by the significant contributions made by our international locations to our financial performance as compared to AMRI’s second quarter performance in 2009. Our ability to deliver high value services combined with our more cost effective facilities in Asia is driving demand throughout our organization. We are also excited about the opportunities now available to us through our recent acquisition of Hyaluron, provi- ding us with immediate entry into the rapidly grow- ing pre-filled syringe market. We are already reali- zing cross selling benefits between our organizations and we are optimistic about the growth and revenue synergy opportunities this acquisition offers.”
Total debt at June 30, 2010 was $13.2 million, down from $13.5 million at December 31, 2009. Cash, cash equivalents, and marketable securities, net of debt, were $47.2 million at June 30, 2010. Total common shares outstanding, net of treasury shares, were 31,791,214 at June 30, 2010.
http://www.amriglobal.com
technologies and systems, reported financial results for the second quarter ended June 30, 2010. Finan-
A
ltair Nanotechnologies, Inc. (NASDAQ: ALTI), a provider of advanced lithium-ion battery
cial Highlights for second quarter 2010 compared to 2009:
• Revenue of $1.5 million compared to $(3,000); • Gross margin of $0.4 million compared to $(0.3); • Operating expenses of $5.5 million compared to $6.2 million;
• Net loss of $4.9 million compared to $6.4 million; • Net cash burn of $4.1 million compared to $(6.7).
In June, Altair Nanotechnologies had been granted a U.S. patent for the “Method of Producing Mixed Metal Oxides and Metal Oxide Compounds.” This patent protects the unique nanotechnology manuf- acturing process for battery anodes and cathodes in lithium-ion batteries utilizing a wider range of metal oxides. Furthermore, Altair has signed a long- term supply agreement with Proterra Inc. to supply advanced lithium-ion battery modules for incorpo- ration into Proterra‘s all-electric and hybrid-electric buses. The initial purchase order of $4.6 million is for delivery of modules through June 2011 with ongoing orders anticipated thereafter as Proterra continues to gain customer traction and completes its state-of-the- art manufacturing facility in Greenville, SC. This is a follow-on order to the two earlier orders announced in August 2009 and April 2010.
http://www.altairnano.com
TSM) announced a long-term agreement that pro- vides TSMC with access to a broad range of ARM processors and enables the development of ARM physical IP across TSMC technology nodes. This ag- reement supports the companies’ mutual customers to achieve optimized Systems-On-Chip (SoC) based
A
RM and Taiwan Semiconductor Manufac- turing Company, Ltd. (TWSE: 2330, NYSE:
10-07/08 :: July/August 2010
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83